Ozone-induced cognitive deficits are mediated by the liver–brain axis: peripheral complement C3 triggers microglial synaptic phagocytosis

Read full text
Authors: Yougang Wang, Haomin Qi, Weiran Dong, Yushan Chen, Désiré Nisubire, Yan Zeng, Jie Li
Cited by: 5
References: 73

Abstract

Ozone (O 3 ) is a significant global air pollutant. Recent epidemiological studies have established a correlation between O 3 exposure and an increased risk of neurological disorders. However, the underlying mechanisms by which O 3 induces cognitive deficits remain unclear. This study demonstrated that exposure to environmentally relevant O 3 levels resulted in significant cognitive impairment in mice. These deficits arose from hippocampal synaptic injury, characterized by reduced dendritic spine density, disrupted synaptic ultrastructure, and impaired long-term potentiation. Mechanistically, O 3 activated the liver complement pathway, leading to increased levels of complement component 3 (C3) and its subsequent release into the bloodstream. Furthermore, O 3 compromised the integrity of the blood–brain barrier, allowing peripheral C3 to infiltrate the hippocampus. Notably, C3 served as a key signal that triggered local pro-inflammatory microglial activation and enhanced their phagocytosis of excitatory synapses, ultimately resulting in synaptic loss and cognitive decline. Importantly, both the microglial inhibitor minocycline and liver-specific C3 knockdown suppressed pro-inflammatory microglial activation and restored synaptic plasticity and cognitive function. These findings systematically reveal a novel liver–brain axis in O 3 neurotoxicity, whereby peripheral C3 drives central microglial phagocytosis of excitatory synapses, offering new mechanistic insights and potential therapeutic targets for O 3 -related neurological diseases.

Fields of Study & Subjects

Neuroinflammation and Neurodegeneration Mechanisms Air Quality and Health Impacts Medical and Biological Ozone Research

Publication details

Journal / source
Journal of Neuroinflammation
Publisher
Springer Science and Business Media LLC
Volume
23
Issue
1
Publication date
19 February 2026
Language
EN